NCT00051922View on ClinicalTrials.gov

Development of a New HIV Vaccine

PHASE1CompletedINTERVENTIONAL
Enrollment

24

Participants

Timeline

Start Date

October 31, 1997

Primary Completion Date

July 31, 2006

Study Completion Date

June 30, 2009

Conditions
HIV Infections
Interventions
BIOLOGICAL

PolyEnv1

Recombinant vaccinia virus vaccine

Trial Locations (1)

38105

St. Jude Children's Research Hospital, Memphis

All Listed Sponsors
lead

National Institute of Allergy and Infectious Diseases (NIAID)

NIH

NCT00051922 - Development of a New HIV Vaccine | Biotech Hunter | Biotech Hunter